Nuveen’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Nuveen’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-11,075	Closed	-$138K	–	1580
2016 Q4	$138K	Sell	11,075 -633	-5%	-$7.62K	﹤0.01%	1466
2016 Q3	$160K	Hold	11,708	–	–	﹤0.01%	1350
2016 Q2	$87K	Buy	11,708 +367	+3%	+$2.75K	﹤0.01%	1279
2016 Q1	$72	Sell	11,341 -561	-5%	-$3.14K	﹤0.01%	1365
2015 Q4	$74	Sell	11,902 -481	-4%	-$3.16K	﹤0.01%	1477
2015 Q3	$72	Hold	12,383	–	–	﹤0.01%	1511
2015 Q2	$102	Sell	12,383 -401	-3%	-$3.55K	﹤0.01%	1552
2015 Q1	$105K	Hold	12,784	–	–	﹤0.01%	1543
2014 Q4	$88K	Sell	12,784 -513	-4%	-$3.21K	﹤0.01%	1571
2014 Q3	$72K	Hold	13,297	–	–	﹤0.01%	1552
2014 Q2	$85K	Buy	+13,297	New	+$91.4K	﹤0.01%	1559

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Nuveen's ARIA Position: Q1 2017 in Review

Nuveen sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 11,075 shares — an estimated $138K sold.

Nuveen first reported a position in ARIA in Q2 2014 and held it in 11 quarters. The position peaked at $160K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Nuveen reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Nuveen sold 11,075 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $138K.
Nuveen first reported a position in Ariad Pharmaceuticals Inc in Q2 2014 and held it in 11 quarters.
Nuveen's Ariad Pharmaceuticals Inc position peaked at $160K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Nuveen's 13F filing for Q1 2017, filed 15 May 2017.